Clinical Trials
A brighter future
Our mission is to advance medicines that will provide a brighter future for patients with serious conditions that are not fully served by existing treatments. Our ability to evaluate the safety and efficacy of new therapies is a fundamental part of the development process. We rely on volunteers to enroll in our studies and are very grateful for their participation.
Serenta Clinical Trial for patients suffering with Familial Adenomatous Polyposis (FAP)
The Serenta trial is a Phase 3 clinical trial for people diagnosed with familial adenomatous polyposis (FAP). The purpose of this trial is to test an experimental treatment, eRapa, to evaluate its ability to improve clinical outcomes in FAP patients vs placebo (inactive substance).
eRapa (encapsulated rapamycin) Named Patient Programme
The eRapa Named Patient Programme has been established to provide access to eRapa, an investigational oral formulation of rapamycin, for certain patients diagnosed with Familial Adenomatous Polyposis (FAP).
